Pegylated interferon &alpha;-2b up-regulates specific CD8+ T cells in patients with chronic hepatitis B

doi:10.3748/wjg.v16.i48.6145

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 48

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3603)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

347

HTML

2712

Figures (1-5)

310

Tables (1-2)

234

Sum=3603

Dec 28, 2010 (publication date) through Jan 26, 2025

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Dec 28, 2010; 16(48): 6145-6150
Published online Dec 28, 2010. doi: 10.3748/wjg.v16.i48.6145

Full Size Figure Download Figure

Figure 1 Frequency of hepatitis B virus epitope tetramer+/CD8+ T cell after pegylated interferon α-2b treatment. The frequency of hepatitis B virus (HBV) specific CD8+ T cells was increased connectively at weeks 4, 8, 12 and 24 after pegylated interferon α-2b treatment with no difference in frequency of HBV core specific CD8+ T cells and HBV env specific T cells.

Citation: Chen J, Wang Y, Wu XJ, Li J, Hou FQ, Wang GQ. Pegylated interferon α-2b up-regulates specific CD8+ T cells in patients with chronic hepatitis B. World J Gastroenterol 2010; 16(48): 6145-6150
URL: https://www.wjgnet.com/1007-9327/full/v16/i48/6145.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i48.6145